The immediate and predictable durability of Genentech’s Susvimo’s for the treatment of patients with neovascular age-related macular degeneration (nAMD) was sustained over five years,
A major randomised clinical trial has found that adjunctive topical corticosteroids and corneal cross-linking do not improve outcomes in bacterial keratitis beyond topical antibiotics
Lily Wegrzynowski has joined the Eyecare Plus National Office team as the organisation’s new Business Development Manager.
Eye care in Australia and New Zealand is poised to enter a new era with the launch of ZEISS Cirrus PathFinder. Cirrus PathFinder is
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
